Fecal Carriage of Carbapenem Resistant Enterobacterales and Associated Factors Among Admitted Patients in Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia

References

• Grundmann H, Livermore D, Giske C, et al. Carbapenem-non-susceptible Enterobacterales in Europe: conclusions from a meeting of national experts. Eurosurveillance. 2010;15(46):19711. doi:10.2807/ese.15.46.19711-en
   Web of Science ®Google Scholar
• Andremont A. Commensal flora may play key role in spreading antibiotic resistance (vol 69, pg 605, 2003). Asm News. 2004;70(2):47.
   Google Scholar
• Mittal G, Gaind R, Kumar D, et al. Risk factors for fecal carriage of carbapenemase producing Enterobacterales among intensive care unit patients from a tertiary care center in India. BMC Microbiol. 2016;16(1):1. doi:10.1186/s12866-016-0763-y
   PubMedGoogle Scholar
• CLSI. Performance standards for antimicrobial susceptibility testing. 30th ed. In: CLSI Supplement M100. Wayne, PA: Clinical and Laboratory Standard Institute; 2022.
   Google Scholar
• Zaidah AR, Mohammad NI, Suraiya S, et al. High burden of Carbapenem-resistant Enterobacterales (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting. Antimicrob Resist Infect Control. 2017;6:1–6. doi:10.1186/s13756-017-0200-5
   Web of Science ®Google Scholar
• Lombardi G, Tanzarella ES, Cutuli SL, et al. Treatment of severe infections caused by ESBL or carbapenemases-producing Enterobacteriaceae. Med Intensiva. 2022;47:34–44. doi:10.1016/j.medine.2022.09.002
   PubMed Web of Science ®Google Scholar
• Guilhaumou R, Benaboud S, Bennis Y, et al. Optimization of the treatment with beta-lactam antibiotics in critically ill patients guidelines from the French Society of Pharmacology and Therapeutics and the French Society of Anaesthesia and Intensive Care Medicine. Crit Care. 2019;23(1):1–20. doi:10.1186/s13054-019-2378-9
   PubMedGoogle Scholar
• Bradley N, Lee Y. Practical implications of new antibiotic agents for the treatment of carbapenem-resistant Enterobacteriaceae. Microbiol Insights. 2019;12:1178636119840367. doi:10.1177/1178636119840367
   Google Scholar
• Day KM, Ali S, Mirza IA, et al. Prevalence and molecular characterization of Enterobacterales producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media. J Antimicrob Chemother. 2013;75(2):187–191.
   Google Scholar
• Tischendorf J, de Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: a systematic review. Am J Infect Control. 2016;44(5):539–543. doi:10.1016/j.ajic.2015.12.005
   PubMed Web of Science ®Google Scholar
• Rai S, Das D, Niranjan DK, Singh NP, Kaur IR. Carriage prevalence of carbapenem-resistant Enterobacteriaceae in stool samples: a surveillance study. Med J Aust. 2014;7(2):64. doi:10.4066/AMJ.2014.1926
   Google Scholar
• Swaminathan M, Sharma S, Blash SP, et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacterales in the setting of endemicity. Am J Infect Control. 2013;34(8):809–817.
   Google Scholar
• Worku M, Getie M, Moges F, Getaneh A. Extended-spectrum beta-lactamase and carbapenemase producing enterobacterales among patients with gastrointestinal complaints in North West Ethiopia. Interdiscip Perspect Infect Dis. 2019;2019:1.
   Google Scholar
• Desta K, Woldeamanuel Y, Azazh A, et al. High gastrointestinal colonization rate with extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalized patients: emergence of carbapenemase-producing K. pneumoniae in Ethiopia. PLoS One. 2016;11(8):e0161685. doi:10.1371/journal.pone.0161685
   PubMed Web of Science ®Google Scholar
• BD Phoenix™ M50. BD Phoenix M50 automated microbiology system users manual 07 ed; 2020.
   Google Scholar
• Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol. 2008;29(10):966–968. doi:10.1086/590661
   PubMed Web of Science ®Google Scholar
• Control CfD, Prevention. Guidance for Control of Carbapenem-Resistant Enterobacterales (CRE). Atlanta: National Center for Emerging and Zoonotic Infectious Diseases, Division of Health Care Quality Promotion, CDC; 2012.
   Google Scholar
• Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098. doi:10.1016/S1473-3099(13)70318-9
   PubMed Web of Science ®Google Scholar
• Liu Q, Liu L, Li Y, Chen X, Yan Q, Liu WE. Fecal carriage and epidemiology of carbapenem-resistant Enterobacteriaceae among hospitalized patients in a University Hospital. Infect Drug Resist. 2019;Volume 12:3935–3942. doi:10.2147/IDR.S233795
   Web of Science ®Google Scholar
• Pantel A, Marchandin H, Prère MF, et al. Faecal carriage of carbapenemase-producing Gram-negative bacilli in hospital settings in southern France. Eur J Clin Microbiol. 2015;34:899–904. doi:10.1007/s10096-014-2298-1
   Google Scholar
• Banach DB, Francois J, Blash S, et al. Active surveillance for carbapenem-resistant Enterobacterales using stool specimens submitted for testing for Clostridium difficile. Infect Prev Pract. 2014;35(1):82–84.
   Google Scholar
• Ogunbosi BO, Moodley C, Naicker P, Nuttall J, Bamford C, Eley B. Colonisation with extended spectrum beta-lactamase-producing and carbapenem-resistant Enterobacterales in children admitted to a paediatric referral hospital in South Africa. PLoS One. 2020;15(11):e0241776. doi:10.1371/journal.pone.0241776
   PubMed Web of Science ®Google Scholar
• Xu Q, Pan F, Sun Y, et al. Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from inpatient children in a pediatric hospital of Shanghai. Infect Drug Resist. 2020;Volume 13:4405–4415. doi:10.2147/IDR.S275549
   Web of Science ®Google Scholar
• Dahab RA, Ibrahim AM, Altayb HN. Phenotypic and genotypic detection of carbapenemase enzymes producing gram-negative bacilli isolated from patients in Khartoum State. F1000Research. 2017;6:1656. doi:10.12688/f1000research.12432.1
   Google Scholar
• Mohan B, Prasad A, Kaur H, Hallur V, Gautam N, Taneja N. Fecal carriage of carbapenem-resistant Enterobacteriaceae and risk factor analysis in hospitalised patients: a single centre study from India. Indian J Med Microbiol. 2017;35(4):555–562. doi:10.4103/ijmm.IJMM_17_144
   PubMed Web of Science ®Google Scholar
• Jaiswal SR, Gupta S, Kumar RS, et al. Gut colonization with carbapenem-resistant Enterobacteriaceae adversely impacts the outcome in patients with hematological malignancies: results of a prospective surveillance study. Mediterr J Hematol Infect Dis. 2018;10(1). doi:10.4084/MJHID.2018.025
   PubMedGoogle Scholar
• Torres-Gonzalez P, Cervera-Hernandez ME, Niembro-Ortega MD, et al. Factors associated to prevalence and incidence of carbapenem-resistant Enterobacteriaceae fecal carriage: a cohort study in a Mexican tertiary care hospital. PLoS One. 2015;10(10):e0139883. doi:10.1371/journal.pone.0139883
   PubMed Web of Science ®Google Scholar
• Solgi H, Badmasti F, Aminzadeh Z, et al. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla NDM-7 and bla OXA-48. Eur J Clin Microbiol & Infect Dis. 2017;36:2127–2135. doi:10.1007/s10096-017-3035-3
   PubMed Web of Science ®Google Scholar
• Kotb S, Lyman M, Ismail G, et al. Epidemiology of carbapenem-resistant Enterobacterales in Egyptian intensive care units using National Healthcare–associated infections surveillance data, 2011–2017. Antimicrob Resist Infect Control. 2020;9(1):1–9. doi:10.1186/s13756-019-0639-7
   PubMed Web of Science ®Google Scholar
• Akani N, Douglas S, Kamani N. Characterization of carbapenem resistant Enterobacterales from patients stool in tertiary hospitals, Port Harcourt, Rivers State, Nigeria; 2022.
   Google Scholar
• Esimone CO, Nworu CS, Udeogaranya OP. Utilization of antimicrobial agents with and without prescription by out-patients in selected pharmacies in South-eastern Nigeria. Pharm World Sci. 2007;29:655–660. doi:10.1007/s11096-007-9124-0
   PubMedGoogle Scholar
• Fakeye TO, Adisa R, Olatunji E. Self-medication among hospitalized patients in selected secondary health facilities in South Western Nigeria. Pharm Pract. 2010;8(4):233. doi:10.4321/S1886-36552010000400005
   PubMedGoogle Scholar
• Shu LB, Lu Q, Sun RH, et al. Prevalence and phenotypic characterization of carbapenem-resistant Klebsiella pneumoniae strains recovered from sputum and fecal samples of ICU patients in Zhejiang Province, China. Infect Drug Resist. 2018;Volume 12:11–18. doi:10.2147/IDR.S175823
   Web of Science ®Google Scholar
• Cantón R, Akóva M, Carmeli Y, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18(5):413–431. doi:10.1111/j.1469-0691.2012.03821.x
   PubMed Web of Science ®Google Scholar
• Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemoth. 2008;62(suppl_1):1–9. doi:10.1093/jac/dkn241
   PubMedGoogle Scholar
• Zhao ZC, Xu XH, Liu MB, Wu J, Lin J, Li B. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. Am J Infect Control. 2014;42(5):e61–4. doi:10.1016/j.ajic.2014.01.024
   PubMed Web of Science ®Google Scholar
• Bhargava A, Hayakawa K, Silverman E, et al. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients: exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol. 2014;35(4):398–405. doi:10.1086/675614
   PubMed Web of Science ®Google Scholar
• Saxena S, Kumar S, Kumar V, Ravinder KA. Risk factors associated with colonization of intestine by carbapenem resistant Enterobacteriaceae in a pediatric ICU. Clin Microbiol Infect. 2020;10(02):75–81.
   Google Scholar
• Salomão M, Guimarães T, Duailibi D, et al. Carbapenem-resistant Enterobacterales in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate. J Hosp Infect. 2017;97(3):241–246. doi:10.1016/j.jhin.2017.08.012
   PubMed Web of Science ®Google Scholar
• Madueño A, García JG, Ramos MJ, et al. Risk factors associated with carbapenemase-producing Klebsiella pneumoniae fecal carriage: a case–control study in a Spanish tertiary care hospital. Am J Infect. 2017;45(1):77–79.
   PubMed Web of Science ®Google Scholar
• Kizilates F, Yakupogullari Y, Berk H, Oztoprak N, Otlu B. Risk factors for fecal carriage of extended-spectrum beta-lactamase-producing and carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains among patients at hospital admission. Am J Infect. 2021;49(3):333–339.
   PubMed Web of Science ®Google Scholar
• Schechner V, Kotlovsky T, Kazma M, et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect. 2013;19(5):451–456. doi:10.1111/j.1469-0691.2012.03888.x
   PubMed Web of Science ®Google Scholar
• Akova M, Daikos GL, Tzouvelekis L, Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect. 2012;18(5):439–448. doi:10.1111/j.1469-0691.2012.03823.x
   PubMed Web of Science ®Google Scholar
• Saidel-Odes L, Borer A. Limiting and controlling carbapenem-resistant Klebsiella pneumoniae. Infect Drug Resist. 2013;7:9–14. doi:10.2147/IDR.S44358
   PubMed Web of Science ®Google Scholar
• Alizadeh N, Ahangarzadeh Rezaee M, Samadi Kafil H, et al. Evaluation of resistance mechanisms in carbapenem-resistant Enterobacteriaceae. Infect Drug Resist. 2020;Volume 13:1377–1385. doi:10.2147/IDR.S244357
   Web of Science ®Google Scholar
• Senchyna F, Gaur RL, Sandlund J, et al. Diversity of resistance mechanisms in carbapenem-resistant Enterobacterales at a health care system in Northern California, from 2013 to 2016. Diagnostic microbiology and infectious disease. Diagn Microbiol Infect Dis. 2019;93(3):250–257. doi:10.1016/j.diagmicrobio.2018.10.004
   PubMed Web of Science ®Google Scholar
• Perry JD, Naqvi SH, Mirza IA, et al. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother. 2011;66(10):2288–2294. doi:10.1093/jac/dkr299
   PubMed Web of Science ®Google Scholar
• Adler A, Katz DE, Marchaim D. The continuing plague of extended-spectrum β-lactamase–producing Enterobacteriaceae infections. Infect Dis Clin. 2016;30(2):347–375. doi:10.1016/j.idc.2016.02.003
   PubMed Web of Science ®Google Scholar
• Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010–2013). Diagn Microbiol Infect Dis. 2015;83(2):183–186. doi:10.1016/j.diagmicrobio.2015.06.011
   PubMed Web of Science ®Google Scholar
• Poirel L, Nordmann P. Lack of polymyxin resistance among carbapenemase-producing Enterobacteriaceae in a university hospital in China. Infect Dis. 2017;49(7):556–557. doi:10.1080/23744235.2017.1292543
   PubMed Web of Science ®Google Scholar